Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Sep 10, 2015
Perrigo Company plc (NYSE: PRGO; TASE) today announced that Perrigo Chairman, President and CEO Joseph C. Papa will present at the Morgan Stanley 2015 Global Healthcare Conference at 12:55 PM EDT...
-
Sep 10, 2015
Perrigo Company plc ("Perrigo") (NYSE: PRGO; TASE) today responded to Mylan N.V.'s ("Mylan") (NASDAQ: MYL) letter to Perrigo dated September 8th, 2015. Perrigo Chairman, President and CEO Joseph...
-
Sep 2, 2015
The Springfield Police Department's K-9 unit will now be protected in the line of duty thanks to the support of PetArmor®, a brand of Perrigo Animal Health, and Walmart. In partnership with...
-
Aug 31, 2015- Leverages Perrigo's expansive U.S. distribution and customer network to accelerate growth of the brand
Perrigo Company plc ("Perrigo") (NYSE: PRGO; TASE) announced today that it has acquired ScarAway®, a leading U.S. OTC scar management brand, from Enaltus, LLC. The brand is expected to generate...
-
Aug 28, 2015- Exemplifies Perrigo's strategic initiative to further scale the Company's consumer-facing business globally
Perrigo Company plc ("Perrigo") (NYSE: PRGO; TASE) today announced that it has completed the acquisition of leading OTC brands from GSK in an all cash transaction valued at €200 million. The...
-
Aug 28, 2015Offer Substantially Undervalues Perrigo, Exposes Shareholders to Risk and Mylan's Weak Business Prospects
Perrigo Company plc ("Perrigo") (NYSE: PRGO; TASE) today commented on the Mylan N.V. ("Mylan") (NASDAQ: MYL) shareholder vote regarding its planned unsolicited offer to acquire Perrigo. "Our views...
-
Aug 26, 2015
The St. Louis Police Department's K-9 unit will now be protected in the line of duty thanks to the support of PetArmor®, a brand of Perrigo Animal Health, and Walmart. In partnership with Vested...
-
Aug 14, 2015- "Proposal would incur significant dilution with almost no subsequent leverage to drive an optimal outcome"
Perrigo Company plc ("Perrigo") (NYSE: PRGO; TASE) today announced that Institutional Shareholder Services ("ISS"), the leading independent proxy advisory firm, recommended that Mylan NV ("Mylan")...
-
Aug 13, 2015- Would further dilute an already dilutive transaction
Perrigo Company plc ("Perrigo," "the Company") (NYSE: PRGO; TASE) today responded to the announcement that Mylan N.V. ("Mylan") has lowered the acceptance condition for its proposed unsolicited...
-
Aug 12, 2015
Perrigo Company plc (NYSE: PRGO;TASE) today announced that its Board of Directors declared a quarterly dividend of $0.125 per share, payable on September 15, 2015 to shareholders of record on...
-
Aug 11, 2015
The Tampa Police Department's K-9 unit will now be protected in the line of duty thanks to the support of PetArmor®, a brand of Perrigo Animal Health and Walmart. In partnership with Vested...
-
Aug 5, 2015
Second Quarter Calendar Year 2015* Highlights: Delivered record quarter net sales of $1.53 billion, comprised of $1.15 billion from consumer-facing businesses. Compared to the prior year, adjusted...
-
Jul 24, 2015
Perrigo Company plc (NYSE: PRGO; TASE) today announced that it will release financial results for its second quarter calendar year 2015 on Wednesday, August 5, 2015 at approximately 8:00 a.m....
-
Jul 22, 2015-- Exemplifies Perrigo's unique brand-building capabilities and impressive distribution network across Europe
Perrigo Company plc ("Perrigo") (NYSE: PRGO; TASE) today announced that it has entered into an agreement to acquire Naturwohl Pharma GmbH with its leading German dietary supplement brand, Yokebe....
-
Jun 16, 2015
Perrigo Company plc (NYSE: PRGO; TASE) today announced that Perrigo Executive Vice President and CFO Judy Brown will present at the Oppenheimer 15th Annual Global Consumer Conference at 11:45 AM ET on
-
Jun 2, 2015-- Portfolio includes well-established European brands in the areas of nicotine replacement therapy, cold and flu, and cold sore management
Perrigo Company plc ("Perrigo") (NYSE: PRGO; TASE) today announced that it has entered into an agreement to acquire a portfolio of well-established over-the-counter ("OTC") brands from...
-
May 27, 2015
Perrigo Company plc (NYSE: PRGO; TASE) today announced that Perrigo Chairman, President and CEO Joseph C. Papa will present at the Jefferies 2015 Healthcare Conference at 4:30 PM EDT on Tuesday,...
-
May 12, 2015
Perrigo Company plc (NYSE: PRGO; TASE) today announced that Perrigo Chairman, President and CEO Joseph C. Papa will present at the 2015 UBS Global Healthcare Conference at 11:30AM EST on Monday,...
-
May 12, 2015-- Further strengthens Perrigo's supply chain capabilities with the addition of softgel manufacturing technology
Perrigo Company plc (NYSE: PRGO; TASE) announced today that it has acquired the Mexican operations of Durham, North Carolina-based Patheon for $34 million in cash. The acquisition is expected to...
-
May 5, 2015
Perrigo Animal Health, a division of Perrigo Company plc (NYSE: PRGO; TASE), today announced that it has launched PetArmor® Joint Health Maximum. PetArmor Joint Health Maximum is a supplement for...
-
Apr 30, 2015
Perrigo Company plc (NYSE: PRGO; TASE) today announced that Perrigo Chairman, President and CEO Joseph C. Papa will present at the 2015 Deutsche Bank 40th Annual Healthcare Conference at 11:20AM...
-
Apr 29, 2015Offer Remains Below Initial April 8th Proposal Based on Unaffected Mylan Stock Price
Perrigo Company plc ("Perrigo") (NYSE: PRGO; TASE) today announced its rejection of the revised unsolicited offer from Mylan NV ("Mylan") (NASDAQ: MYL) to acquire all of the outstanding shares of...
-
Apr 28, 2015
Perrigo Company plc (NYSE: PRGO; TASE) today announced that its Board of Directors declared a quarterly dividend of $0.125 per share, payable on June 16, 2015 to shareholders of record on May 29,...
-
Apr 24, 2015Offer Significantly Below Prior Proposal Based on Unaffected Mylan Stock Price
Perrigo Company plc ("Perrigo" or the "Company") (NYSE: PRGO, TASE) today announced its rejection of the unsolicited offer from Mylan NV ("Mylan") (NASDAQ: MYL) to acquire all of the outstanding...
-
Apr 22, 2015
Dublin, Ireland – April 22, 2015 – On April 16, Perrigo Company plc (NYSE: PRGO; TASE) announced it had received final U.S. Food and Drug Administration approval and had launched the...